Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
US7700586B2 · kind B2 · utility
13Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2002 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | May 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.